CureVac and GSK will receive $740 million and single-digit royalties on COVID-19 vaccine sales in the U.S. going forward.

As part of Sanner’s strategic transformation into a Contract Development and Manufacturing Organization (CDMO) for medical ...

Intas Pharmaceuticals in collaboration with its global Accord brand subsidiaries, has acquired UDENYCA (pegfilgrastim-cbqv) ...

Advarra, a provider of clinical research technology, expanded its Study Collaboration, a study startup technology designed to ...

Marken's Mike Bartone, VP of Global Cold Chain Solutions Management, on scaling temperature-controlled precision logistics, ...

Emerging therapies targeting GD2, a marker highly expressed in neuroblastoma, offer tremendous promise. FDA-approved ...

Founded in 1997, VEG built its reputation through its deep engineering expertise across a range of CQV services. The ...

Minghui Pharmaceutical ( Minghui ), a late-stage clinical biopharmaceutical company, announced the closing of a $131 million ...

The expansion increases output, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ...

David King of Samsung Biologics shares insights on market demand and the technologies and capabilities needed to support ...

To layoff 5,000 employees by the end of the year; aims to reduce operating expenses by approximately $1.5 billion by 2027.

This platform aims to deliver high-quality cyclic peptides with faster timelines and better economy across a broad range of ...